Trivium Point Advisory’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$513K Sell
11,073
-208
-2% -$9.63K 0.06% 235
2025
Q1
$688K Buy
11,281
+1,489
+15% +$90.8K 0.09% 200
2024
Q4
$554K Buy
9,792
+1,899
+24% +$107K 0.07% 214
2024
Q3
$461K Buy
7,893
+620
+9% +$36.2K 0.06% 228
2024
Q2
$302K Buy
7,273
+1,124
+18% +$46.7K 0.05% 248
2024
Q1
$333K Buy
6,149
+1,493
+32% +$81K 0.07% 185
2023
Q4
$239K Sell
4,656
-257
-5% -$13.2K 0.06% 182
2023
Q3
$281K Sell
4,913
-38
-0.8% -$2.17K 0.08% 165
2023
Q2
$317K Sell
4,951
-279
-5% -$17.8K 0.09% 165
2023
Q1
$362K Sell
5,230
-38
-0.7% -$2.63K 0.1% 160
2022
Q4
$385K Sell
5,268
-38
-0.7% -$2.77K 0.11% 153
2022
Q3
$373K Sell
5,306
-276
-5% -$19.4K 0.12% 154
2022
Q2
$419K Sell
5,582
-1,837
-25% -$138K 0.13% 154
2022
Q1
$559K Sell
7,419
-499
-6% -$37.6K 0.12% 162
2021
Q4
$494K Buy
7,918
+917
+13% +$57.2K 0.1% 165
2021
Q3
$413K Sell
7,001
-16,832
-71% -$993K 0.1% 165
2021
Q2
$1.59M Sell
23,833
-2,513
-10% -$168K 0.4% 88
2021
Q1
$1.66M Sell
26,346
-2,735
-9% -$173K 0.45% 82
2020
Q4
$1.81M Sell
29,081
-1,527
-5% -$95.2K 0.52% 60
2020
Q3
$1.85M Sell
30,608
-1,047
-3% -$63.1K 0.65% 49
2020
Q2
$1.91M Buy
31,655
+24,179
+323% +$1.46M 0.75% 40
2020
Q1
$435K Buy
7,476
+3,740
+100% +$218K 0.22% 105
2019
Q4
$240K Sell
3,736
-1,049
-22% -$67.4K 0.09% 148
2019
Q3
$243K Buy
4,785
+339
+8% +$17.2K 0.11% 140
2019
Q2
$202K Sell
4,446
-376
-8% -$17.1K 0.09% 159
2019
Q1
$230K Buy
4,822
+810
+20% +$38.6K 0.11% 146
2018
Q4
$209K Buy
+4,012
New +$209K 0.13% 131